Gene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model

Journal of Infectious Diseases

Volumn 211, Issue 9, 2015, Pages 1499-1509

  Matsumiya, Magali ^a   Satti, Iman ^a   Chomka, Agnieszka ^a   Harris, Stephanie A ^a   Stockdale, Lisa ^a   Meyer, Joel ^a   Fletcher, Helen A ^a,b   McShane, Helen ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

BCG; Cytokines; Transcriptomics; Tuberculosis; Vaccines

Indexed keywords

BCG VACCINE; CYTOKINE; DNA;

ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA MICROARRAY; DRUG EFFICACY; DRUG MECHANISM; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; INCIDENCE; MICROARRAY ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SKIN BIOPSY; TUBERCULOSIS; UNITED KINGDOM; VACCINATION; APOPTOSIS; BACTERIAL SKIN DISEASE; CONTROLLED CLINICAL TRIAL; GENE EXPRESSION REGULATION; GENETICS; GLYCOLYSIS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MICROBIOLOGY; MONONUCLEAR CELL; MYCOBACTERIUM BOVIS; T LYMPHOCYTE;

APOPTOSIS; BCG VACCINE; CYTOKINES; GENE EXPRESSION REGULATION; GLYCOLYSIS; HUMANS; IMMUNITY, INNATE; LEUKOCYTES, MONONUCLEAR; MYCOBACTERIUM BOVIS; SKIN DISEASES, BACTERIAL; T-LYMPHOCYTES;

EID: 84928911689     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu615     Document Type: Article

References (31)

1. WHO. Global tuberculosis report 2013. Geneva: WHO, 2013.
2. Colditz GA, Brewer TF, Berkey CS, Burdick E, Fineberg HV, Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. JAMA 1994; 271:698-702.
3. Ottenhoff THM, Kaufmann SHE. Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog 2012; 8:e1002607.
4. Tameris MD, Hatherill M, Landry BS, et al. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 2013; 6736:1-8.
5. Harris SA, Meyer J, Satti I, et al. Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination. J Infect Dis 2014; 209:1259-68.
6. Minassian AM, Satti I, Poulton ID, Meyer J, Hill AVS, McShane H. A human challenge model for Mycobacterium tuberculosis using Mycobac-terium bovis bacille Calmette-Guerin. J Infect Dis 2012; 205:1035-42.
7. Griffiths KL, Pathan AA, Minassian AM, et al. Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A. PLoS One 2011; 6:e23463.
8. Hanekom WA, Hughes J, Mavinkurve M, et al. Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. J Immunol Methods 2004; 291: 185-95.
9. Kauffmann A, Huber W. Microarray data quality control improves the detection of differentially expressed genes. Genomics 2010; 95:138-42.
10. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: 2011.
11. Smyth GK. limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, eds. Bioinformatics and computational biology solutions using R and bioconductor. New York: Springer, 2005:397-420.
12. Ritchie ME, Diyagama D, Neilson J, et al. Empirical array quality weights in the analysis of microarray data. BMC Bioinformatics 2006; 7:261.
13. Shi W, Oshlack A, Smyth GK. Optimizing the noise versus bias trade-off for Illumina whole genome expression BeadChips. Nucleic Acids Res 2010; 38:e204.
14. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4:44-57.
15. Warnes AGR, Bolker B, Bonebakker L, et al. Gplots: various R programming tools for plotting data 2011.
16. Medical Research Council. BCG and Vole Bacillus vaccines in the prevention of Tuberculosis in adolescence and early adult life. Br Med J 1963; 1:973-8.
17. Marsay L, Matsumiya M, Tanner R, et al. Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Myco-bacterium tuberculosis (M. tb). Tuberculosis (Edinb) 2013; 93:551-7.
18. Wozniak TM, Saunders BM, Ryan AA, Britton WJ. Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Myco-bacterium tuberculosis infection in the absence of gamma interferon. Infect Immun 2010; 78:4187-94.
19. Gopal R, Lin Y, Obermajer N, et al. IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination. Eur J Immunol 2012; 42:364-73.
20. Pitt JM, Stavropoulos E, Redford PS, et al. Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection. J Immunol 2012; 189:4079-87.
21. Bhuju S, Aranday-Cortes E, Villarreal-Ramos B, Xing Z, Singh M, Vor-dermeier HM. Global gene transcriptome analysis in vaccinated cattle revealed a dominant role of IL-22 for protection against bovine tuberculosis. PLoS Pathog 2012; 8:e1003077.
22. Kleinnijenhuis J, Quintin J, Preijers F, et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci USA 2012; 109:17537-42.
23. Darrah PA, Patel DT, De Luca PM, et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007; 13:843-50.
24. Soares AP, Kwong Chung CKC, Choice T, et al. Longitudinal changes in CD4(+) T-cell memory responses induced by BCG vaccination of new-borns. J Infect Dis 2013; 207:1084-94.
25. Henao-Tamayo M, Ordway DJ, Orme IM. Memory T cell subsets in tuberculosis: What should we be targeting? Tuberculosis (Edinb) 2014; 94:455-61.
26. Cunha AJLA, Sant'Anna CC, Mannarino R, Labanca TC, Ferreira S, March MFBP. Adverse effects of BCG revaccination: a report on 13 cases from Rio de Janeiro, Brazil. Int J Tuberc Lung Dis 2002; 6:1110-3.
27. Dourado I, Rios MH, Pereira SMM, et al. Rates of adverse reactions to first and second doses of BCG vaccination: results of a large community trial in Brazilian schoolchildren. Int J Tuberc Lung Dis 2003; 7:399-402.
28. Lalor MK, Floyd S, Gorak-Stolinska P, et al. BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi. J Infect Dis 2011; 204:1075-85.
29. Rook GA, Dheda K, Zumla A. Immune responses to tuberculosis in developing countries: implications for new vaccines. Nat Rev Immunol 2005; 5:661-7.
30. Khader SA, Gopal R. IL-17 in protective immunity to intracellular pathogens. Virulence 2010; 1:423-7.
31. Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201:233-40.